If the ultimate measure of a society is how it takes care of its most vulnerable, then the work of startups like Incereb should be commandeering the spotlight. Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. They are developing neonatal brain monitoring devices which are designed to be used in maternity delivery rooms and neonatal intensive care units. Their disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products bring revolutionary change to the field of neonatal care by optimising care for the most fragile of patients: term and preterm infants.
Established in May 2011 and based in Dublin, Ireland, their strategic alliances with leading Irish universities and hospitals fuel their relentless pursuit of scientific excellence. Not only do these alliances help fast-track commercialisation of novel devices, but they also feed into rapid company growth. Guided by a vision to lead the market in neonatal brain monitoring devices, Incereb continues to invest heavily in research and development, product design, and development.
Key Takeaways
- Incereb Ltd designs, develop, and commercialises intuitive neonatal brain monitoring devices.
- Founded and based in Dublin, Ireland, the company collaborates with leading Irish universities and hospitals for fast track product commercialisation and company growth.
- Incereb’s neonatal brain monitoring devices interface with all brands of EEG and CFM recording equipment.
- The company continues to invest heavily in research and development, product design, and development to continuously enhance their product range.
What sets Incereb apart in its field is its dedication to creating intuitive products that require minimal training. In a medical environment where every second counts, their EEG and CFM products significantly reduce the time taken to set up the neonate for the necessary monitoring procedures. This streamlining of procedures is a game-changer in the NICU. The fact that Incereb’s products can interface with all brands of EEG and CFM recording equipment brings exceptional versatility to the neonatal care environment.
The company has already been recognised and awarded as an early stage company, a clear sign of its groundbreaking efforts so far. Their continued heavy investment in research and development, product design, and development ensure an ongoing cycle of evolution and extension of product ranges.
The future looks promising for Incereb and the industry it operates within. With technology and medical science collaborating for the betterment of newborn care, continuous innovations are on the horizon. As Incereb’s products become more widespread and their benefits more widely appreciated, the potential for their growth and impact is immense.
In an industry where the stakes could not be higher, the future of neonatal care looks brighter thanks to startups like Incereb. We encourage our readers to follow and support their journey at www.incereb.com and on their social media platforms: Twitter, LinkedIn. Let’s continue in our collective efforts to support advancements in medical technology across Europe and worldwide.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
